Methods This prospective multicenter AF registry study comprised 6,067 patients with AF
(mean age, 70±9 years; men, 59%) with intermediate to high risk of stroke (CHA 2 DS 2 …

Background: Gender is a well-recognized risk factor in atrial fibrillation (AF)-related ischemic
stroke. The association of gender with the use of oral anticoagulants (OACs) and prognosis …

Background: Sex-related difference in non-valvular atrial fibrillation (NVAF) patients treated
with direct oral anticoagulants (DOACs) is still to be investigated. We aimed to investigate …

Background: Women with atrial fibrillation are at a higher risk of stroke, despite treatment
with warfarin. It is unclear if women treated with direct oral anticoagulants (DOACs) have …

Background While many risk factors for Atrial Fibrillation (AF) have been identified, there are
important differences in their relative impact between sexes. The aim of our study was to …

Aims To investigate sex‐specific temporal trends in the initiation of oral anticoagulant (OAC)
therapy among patients diagnosed with atrial fibrillation (AF) in Finland between 2007 and …

Studies comparing gender-specific outcomes in patients with atrial fibrillation (AF) have
reported conflicting results. Gender differences in cerebrovascular accident/systemic …

The efficacy of adjusted-dose oral anticoagulant treatment (OAT) in the prevention of stroke
in atrial fibrillation (AF) is well documented. Available data show that AF patients are widely …

Background Important disparities in the treatment and outcomes of women and men with
atrial fibrillation (AF) are well recognized. Whether introduction of direct oral anticoagulants …

Atrial fibrillation (AF) is the most common sustained arrhythmia. Thromboembolic events
related to AF result in significant morbidity and mortality. An individual's risk of …